IPOGrid
0002108359
IPO filing research

BioKey (Cayman), Inc.

Pharmaceutical Preparations

ipo filed DRS

BioKey (Cayman), Inc. IPO research page with SEC filing history, offering status, deal terms, structured filing extracts, company news, and comparable IPO context. Latest filing: DRS on 2026-02-11.

Filing Timeline

SEC EDGAR
DRS filed
Draft registration statement
Draft registration filed confidentially before the public launch.
First tracked pre-IPO filing for this issuer.
BioKey (Cayman), Inc. has submitted a confidential Form 10 registration statement for securities, incorporating by reference information from an Information Statement. The filing indicates the company is a Cayman Islands exempted company preparing for potential public offerings, with no securities registered under Section 12(b) but intending to register ordinary shares. The document emphasizes confidential treatment of information and references legal agreements related to corporate structure and operations.
2026-02-11 ยท 0001213900-26-014665

Recent News

No recent news stored for this issuer.